FDA Inspection 1168208 — Octapharma Plasma Inc

Octapharma Plasma Inc — FEI 3013156936

The FDA completed an inspection of Octapharma Plasma Inc on Apr 27, 2022 in Reynoldsburg, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 27, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Reynoldsburg, OH (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs